Real-time enrollment status for this urothelial cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:20 AM UTC
| NCT Number | NCT07869836 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Cancer |
| Phase | PHASE3 |
| Target Enrollment | 520 participants |
| Active Locations | 2 sites in the US |
| Sponsor | SystImmune Inc. |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT07869836 is currently recruiting participants. This phase3 study for urothelial cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by SystImmune Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07869836 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07869836 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.